相似文献
1
The Profound Impact of Gastrointestinal Stasis on Levodopa Response in Parkinson's Disease.
Mov Disord Clin Pract. 2022 Feb 25;9(3):394-396. doi: 10.1002/mdc3.13425. eCollection 2022 Apr.
2
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
Brain. 2012 May;135(Pt 5):1478-85. doi: 10.1093/brain/aws086. Epub 2012 Apr 19.
3
Gastric emptying time and gastric motility in patients with Parkinson's disease.
Mov Disord. 2001 Nov;16(6):1041-7. doi: 10.1002/mds.1203.
4
Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.
J Neurol. 2009 Dec;256(12):1972-6. doi: 10.1007/s00415-009-5220-5.
5
Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.
Isr J Med Sci. 1996 Dec;32(12):1224-7.
6
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
J Neurol Sci. 2012 Aug 15;319(1-2):86-8. doi: 10.1016/j.jns.2012.05.010. Epub 2012 May 25.
7
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease.
Parkinsonism Relat Disord. 2020 Jul;76:63-71. doi: 10.1016/j.parkreldis.2020.05.001. Epub 2020 May 11.
8
Delayed gastric emptying in Parkinson's disease.
Mov Disord. 2014 Jan;29(1):23-32. doi: 10.1002/mds.25708. Epub 2013 Oct 21.
9
Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
J Neural Transm Suppl. 1999;56:173-83. doi: 10.1007/978-3-7091-6360-3_11.
10
Irregular gastrointestinal drug absorption in Parkinson's disease.
Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):193-203. doi: 10.1517/17425255.4.2.193.
引用本文的文献
1
Sublingual apomorphine in the treatment of Parkinson's disease.
J Neural Transm (Vienna). 2024 Oct;131(10):1209-1216. doi: 10.1007/s00702-024-02777-z. Epub 2024 May 14.
2
A multifaceted comparative analysis of image and video technologies in gastrointestinal endoscope and their clinical applications.
Front Med (Lausanne). 2023 Oct 10;10:1226748. doi: 10.3389/fmed.2023.1226748. eCollection 2023.
本文引用的文献
1
Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management.
Brain Sci. 2021 Jun 23;11(7):831. doi: 10.3390/brainsci11070831.
2
Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21.
3
Gastric emptying in Parkinson's disease - A mini-review.
Parkinsonism Relat Disord. 2018 Oct;55:18-25. doi: 10.1016/j.parkreldis.2018.06.003. Epub 2018 Jun 6.
4
Gastrointestinal dysfunction in Parkinson's disease.
Lancet Neurol. 2015 Jun;14(6):625-39. doi: 10.1016/S1474-4422(15)00007-1.
5
Gastroparesis and Parkinson's disease: a systematic review.
Parkinsonism Relat Disord. 2012 Jun;18(5):433-40. doi: 10.1016/j.parkreldis.2011.12.004. Epub 2011 Dec 29.
6
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.
Parkinsonism Relat Disord. 2005 Dec;11(8):499-502. doi: 10.1016/j.parkreldis.2005.06.007. Epub 2005 Nov 2.
7
Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test.
Neurosci Lett. 2005 Mar 3;375(3):170-3. doi: 10.1016/j.neulet.2004.11.007. Epub 2004 Nov 30.
8
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Mov Disord. 2005 Feb;20(2):190-9. doi: 10.1002/mds.20324.
9
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Mov Disord. 1997 Nov;12(6):952-7. doi: 10.1002/mds.870120618.
10
Gastric emptying in Parkinson's disease: patients with and without response fluctuations.
Neurology. 1996 Apr;46(4):1051-4. doi: 10.1212/wnl.46.4.1051.
Zotero 插件